Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M575Revenue (TTM) $M28.2Net Margin (%)-584.8Altman Z-Score-6.0
Enterprise Value $M533EPS (TTM) $-1.6Operating Margin %-404.9Piotroski F-Score3
P/E(ttm)--Beneish M-Score65.0Pre-tax Margin (%)-584.5Higher ROA y-yN
Price/Book24.510-y EBITDA Growth Rate %--Quick Ratio7.4Cash flow > EarningsY
Price/Sales19.05-y EBITDA Growth Rate %29.5Current Ratio8.8Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-80.7Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-243.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M106ROIC % (ttm)-2,239.1Gross Margin Increase y-yN

Gurus Latest Trades with KERX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
KERXJoel Greenblatt 2016-09-30 Sold Out -0.01%$4.1 - $7.53
$ 5.431%Sold Out0
KERXJoel Greenblatt 2016-06-30 Add0.01%$4.54 - $6.76
$ 5.43-3%Add 206.30%77,976
KERXJoel Greenblatt 2016-03-31 Buy $3.17 - $5.38
$ 5.4336%New holding25,457
KERXSeth Klarman 2015-06-30 Add0.57%$9.32 - $12.73
$ 5.43-49%Add 15.24%25,791,678
KERXSeth Klarman 2015-03-31 Add0.88%$10.87 - $14.68
$ 5.43-58%Add 22.30%22,380,200
KERXSeth Klarman 2014-09-30 Add1.87%$12.71 - $18.19
$ 5.43-65%Add 73.62%18,300,000
KERXSeth Klarman 2014-06-30 Add1.04%$12.11 - $17.03
$ 5.43-62%Add 67.01%10,539,986
KERXSeth Klarman 2014-03-31 Buy 2.6%$12.16 - $16.88
$ 5.43-64%New holding6,310,850
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

KERX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

KERX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Adams BrianVP and General Counsel 2017-01-17Sell1,265$6.24-12.66view
Adams BrianVP and General Counsel 2017-01-05Sell759$6.16-11.53view
Madison GregPresident and CEO 2017-01-05Sell1,077$6.16-11.53view
Madison GregPresident and CEO 2016-11-09Sell1,559$4.999.22view
Holmes Scott ACFO 2016-10-28Sell1,237$4.4422.75view
Neylan John F.Chief Medical Officer 2016-10-24Sell1,211$4.7215.47view
Adams BrianVP and General Counsel 2016-10-17Sell1,106$4.8612.14view
Madison GregPresident and CEO 2016-10-05Sell917$5.381.3view
Adams BrianVP and General Counsel 2016-10-05Sell647$5.381.3view
Madison GregPresident and CEO 2016-08-09Sell1,622$4.2229.15view

Quarterly/Annual Reports about KERX:

News about KERX:

Articles On GuruFocus.com
Seth Klarman Buys 25 Million Shares of Cascadian Therapeutics as Price Declines Jul 12 2016 
Klarman Gives Insight on Keryx Biopharmaceuticals Investment Jan 26 2016 
Seth Klarman Blames Market, Investments for Rare Down Year Jan 25 2016 
David Abrams Buys Stake in Heavy Equipment Company Dec 15 2015 
Why Seth Klarman Keeps Buying Keryx Biopharma Nov 03 2015 
Seth Klarman Raises Position in Keryx Biopharmaceuticals Oct 21 2015 
Seth Klarman Buys Pharmaceutical Company's Shares to Fund Drug Launch Oct 12 2015 
Is Seth Klarman right about Keryx Inc.? Jun 25 2015 
Seth Klarman Buys Pioneer Natural Resources, SunEdison Semiconductor Ltd, Atara Biotherapeutics Inc, May 15 2015 
Analysts Positive on Keryx Biopharmaceuticals, Inc. Despite Weak Prescription Data May 05 2015 

More From Other Websites
Keryx Biopharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : KERX-US :... Jan 20 2017
Keryx Releases Auryxia Data for Iron Deficiency Anemia Jan 13 2017
Keryx Biopharmaceuticals Announces Publication of Auryxia® (ferric citrate) Phase 3 Trial Results... Jan 12 2017
Keryx Biopharma upgraded by Citigroup Jan 11 2017
KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 09 2017
Keryx Biopharmaceuticals Announces Recent Business Progress and Reviews Corporate Strategy at 35th... Jan 08 2017
Robbins Arroyo LLP: Keryx Biopharmaceuticals, Inc. (KERX) Misled Shareholders According to a... Jan 05 2017
ETFs with exposure to Keryx Biopharmaceuticals, Inc. : January 3, 2017 Jan 03 2017
Implied Volatility Surging for Keryx (KERX) Stock Options Dec 30 2016
Keryx Biopharmaceuticals to Webcast its Presentation at J.P. Morgan’s 35th Annual Healthcare... Dec 22 2016
ETFs with exposure to Keryx Biopharmaceuticals, Inc. : December 19, 2016 Dec 19 2016
Favorite Healthcare Stocks of Billionaire Seth Klarman’s Baupost Group Dec 15 2016
Do Hedge Funds Love Keryx Biopharmaceuticals Inc (KERX)? Dec 11 2016
ETFs with exposure to Keryx Biopharmaceuticals, Inc. : December 5, 2016 Dec 05 2016
ETFs with exposure to Keryx Biopharmaceuticals, Inc. : November 23, 2016 Nov 23 2016
Keryx Biopharmaceuticals, Inc. :KERX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 21,... Nov 21 2016
Keryx Biopharmaceuticals Announces Case Study Data of Auryxia® Presented at ASN’s Kidney Week Nov 18 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)